World Congress on Rare Diseases & Orphan Drugs

Cenetri Publishing Group looks forward to welcoming all the participants across the Globe to attend World Congress on Rare Diseases and Orphan Drugs (RDOD 2018) will be held from December 3-5 in Budapest, Hungary in collaboration with Hungarian Rare Disease Federation. RDOD 2018 delivers a premier interdisciplinary platform for researchers to present the cutting-edge research findings and define emerging technologies, hear from the experts and join the conversation in rare diseases and orphan drugs issues.                                 

The conference highlights the theme: Novel Technologies and Innovations for treatment of Rare Diseases

Why should Attend?

We inspire scientists, researchers, executives and students from the pharmaceutical and biotech communities, associations and societies who are keen to learn more and to network in collaborative environs of rare disease drug discovery to join.

• Learn more about global developments in rare diseases and orphan drugs and its advances in the therapeutic and diagnostic market.
• Deliberating strategic collaborations to accelerate rare disease clinical drug development, and improve connections between drug developers and patients to consider both parties interests.
• Learn more about how patient engagement by assimilating the patient perspective into the drug development process through patient advocacy, patient-centric research, and patient groups
• Hear about how the regulatory landscape for drug approvals is different between countries, and why it is imperative to keep informed about the regulations and guidelines of each region
• Advanced knowledge of different rare diseases and their unique challenges, as well as how treatment methods can be reassigned to other rare diseases
• Introducing cell and gene therapies to rare disease treatment - learn how gene therapy methods can advance the treatment of rare diseases and why it is fetching more commercially successful

Who to Attend?

RDOD 2018 is designed for representatives from pharmaceutical, biotechnology, and medical device companies as well as members of the rare disease community with responsibilities in the following areas:

• Directors, Board Members, Presidents, Vice Presidents, Deans and Head of the Departments
• Researchers, Scientists, Faculties, Students
• Rare Diseases Associations and Societies
• Patient Liaisons/Patient Advocacy Liaisons
• Alliance Management
• Industrial delegates from Academia and Research
• Industrial professionals from biomedical companies and healthcare sectors
• Medical Devices Manufacturing Companies
• Drug Manufacturing Companies and Industries
• Laboratory Technicians and Diagnostic Companies
• Business Entrepreneurs and Industrialists
• Healthcare Professionals and their Associations
• Healthcare Regulators and Consumer Associations

Sessions/Tracks

• Different types of Rare Diseases
• Challenges in Rare Diseases Treatment
• Rare Infectious Diseases and Immune Deficiencies
• Rare Diseases in Cancer
• Rare Diseases in Aging
• Neglected Tropical Diseases
• Rare Pulmonary Diseases
• Rare Pediatric Diseases
• Rare Genetic Diseases
• Rare Cardiac Diseases
• Rare Eye and Ear Diseases
• Rare Oral Diseases
• Rare Hepatic Diseases
• Rare Skin Diseases
• Orphan Drugs- development trends and strategies
• Clinical Research on Orphan Drugs
• Orphan Drugs Policy and Ethical Issues
• Global Patient Advocacy
• Value-based pricing & reimbursement